U.K.’s life sciences sector dodges Labour bullet, concerns about relationship with EU remain

British biotech may have dodged a bullet with the Conservative victory, but the sector’s long-term fate, like that of the country, remains uncertain in the wake of an election that will result in a breach with the European Union. Long-term concerns include whether British biotech companies will be able to attract capital and talent, and

Read the full 556 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers